When you eat a meal, GLP-1 is released into your bloodstream and does several things simultaneously: it signals to your brain that you're full, slows the rate at which your stomach empties food into the intestine, stimulates your pancreas to release insulin in proportion to blood sugar levels, and suppresses glucagon (a hormone that would otherwise raise blood sugar)
This proactive monitoring catches temperature problems before they compromise your medication
About 83 percent of participants on a 10-mg dose achieved an A1C of less than 7 percent, and 85 percent of participants on a 15-mg dose achieved an A1C lower than 7 percent
For those sensitive to needles, a numbing cream may be applied to the injection site to reduce any discomfort during the procedure
The medication works by activating both GIP and GLP-1 receptors, enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite